Advances have recently been made in both medical and surgical management of priapism, and these offer improvements in the level of care afforded such patients. Further developments can be expected based on ongoing progress, particularly in the area of molecular science, which is the primary source for driving novel therapeutic approaches. Continued action to address the health care administrative concerns of those most commonly affected by priapism, specifically individuals with sickle cell disease, is also appropriate. All successes in these arenas ensure that afflicted individuals avoid the health burdens of priapism and preserve sexual function.
|Original language||English (US)|
|Number of pages||10|
|Journal||Urologic Clinics of North America|
|State||Published - May 2011|
- Erectile dysfunction
- Ischemic priapism
ASJC Scopus subject areas